These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 8189506)

  • 1. The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.
    Kirchhoff F; Mori K; Desrosiers RC
    J Virol; 1994 Jun; 68(6):3682-92. PubMed ID: 8189506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1993 Jul; 195(1):167-74. PubMed ID: 8317093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
    Gibbs JS; Regier DA; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ability of the V3 loop of simian immunodeficiency virus to serve as a target for antibody-mediated neutralization: correlation of neutralization sensitivity, growth in macrophages, and decreased dependence on CD4.
    Means RE; Matthews T; Hoxie JA; Malim MH; Kodama T; Desrosiers RC
    J Virol; 2001 Apr; 75(8):3903-15. PubMed ID: 11264379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The intracytoplasmic domain of the Env transmembrane protein is a locus for attenuation of simian immunodeficiency virus SIVmac in rhesus macaques.
    Shacklett BL; Weber CJ; Shaw KE; Keddie EM; Gardner MB; Sonigo P; Luciw PA
    J Virol; 2000 Jul; 74(13):5836-44. PubMed ID: 10846063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain-specific neutralizing determinant in the transmembrane protein of simian immunodeficiency virus.
    Kodama T; Burns DP; Silva DP; Veronese FD; Desrosiers RC
    J Virol; 1991 Apr; 65(4):2010-8. PubMed ID: 1705994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A MHC class I B locus allele-restricted simian immunodeficiency virus envelope CTL epitope in rhesus monkeys.
    Yasutomi Y; McAdam SN; Boyson JE; Piekarczyk MS; Watkins DI; Letvin NL
    J Immunol; 1995 Mar; 154(5):2516-22. PubMed ID: 7532670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence against extracellular exposure of a highly immunogenic region in the C-terminal domain of the simian immunodeficiency virus gp41 transmembrane protein.
    Postler TS; Martinez-Navio JM; Yuste E; Desrosiers RC
    J Virol; 2012 Jan; 86(2):1145-57. PubMed ID: 22072749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SIVmac expressing hybrid envelope proteins containing HIV-1 V3 and/or C4 sequences is not competent for replication.
    Kirchhoff F; Morrison HG; Murray MG; Rennert P; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Mar; 10(3):309-13. PubMed ID: 8018392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of mutations in constant regions 3 and 4 of envelope of simian immunodeficiency virus.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1995 Jul; 210(2):448-55. PubMed ID: 7618279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human immunodeficiency virus type 1 tropism for T-lymphoid cell lines: role of the V3 loop and C4 envelope determinants.
    Carrillo A; Ratner L
    J Virol; 1996 Feb; 70(2):1301-9. PubMed ID: 8551600
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity.
    Page KA; Stearns SM; Littman DR
    J Virol; 1992 Jan; 66(1):524-33. PubMed ID: 1727497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain.
    Ivanoff LA; Looney DJ; McDanal C; Morris JF; Wong-Staal F; Langlois AJ; Petteway SR; Matthews TJ
    AIDS Res Hum Retroviruses; 1991 Jul; 7(7):595-603. PubMed ID: 1768461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An epitope on the surface envelope glycoprotein (gp130) of simian immunodeficiency virus (SIVmac) involved in viral neutralization and T cell activation.
    Torres JV; Malley A; Banapour B; Anderson DE; Axthelm MK; Gardner MB; Benjamini E
    AIDS Res Hum Retroviruses; 1993 May; 9(5):423-30. PubMed ID: 7686386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient transcription and replication of simian immunodeficiency virus in the absence of NF-kappaB and Sp1 binding elements.
    Ilyinskii PO; Desrosiers RC
    J Virol; 1996 May; 70(5):3118-26. PubMed ID: 8627791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
    Gibbs JS; Regier DA; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):333-42. PubMed ID: 8068413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basic amino acid residues in the V3 loop of simian immunodeficiency virus envelope alter viral coreceptor tropism and infectivity but do not allow efficient utilization of CXCR4 as entry cofactor.
    Meister S; Otto C; Papkalla A; Krumbiegel M; Pöhlmann S; Kirchhoff F
    Virology; 2001 Jun; 284(2):287-96. PubMed ID: 11384227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selection for neutralization resistance of the simian/human immunodeficiency virus SHIVSF33A variant in vivo by virtue of sequence changes in the extracellular envelope glycoprotein that modify N-linked glycosylation.
    Cheng-Mayer C; Brown A; Harouse J; Luciw PA; Mayer AJ
    J Virol; 1999 Jul; 73(7):5294-300. PubMed ID: 10364275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neutralising epitopes of simian immunodeficiency virus envelope glycoprotein.
    Kent KA
    J Med Primatol; 1995 May; 24(3):145-9. PubMed ID: 8751054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibodies of symptomatic human immunodeficiency virus type 1-infected individuals are directed to the V3 domain of noninfectious and not of infectious virions present in autologous serum.
    Schreiber M; Petersen H; Wachsmuth C; Müller H; Hufert FT; Schmitz H
    J Virol; 1994 Jun; 68(6):3908-16. PubMed ID: 8189527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.